✦ LIBER ✦

Serum S100B as a biochemical marker of neurological complications in intensive care patients

✍ Scribed by A Raabe,O Kopetsch,A Woszcyk,V Seifert

Book ID: 126386821
Publisher: Springer (Biomed Central Ltd.)
Year: 2002
Tongue: English
Weight: 1021 KB
Volume: 6
Category: Article
ISSN: 1466-609X
DOI: 10.1186/cc1757

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum S100B as a marker of brain damage

Serum S100B as a marker of brain damage in the trauma intensive care unit

✍ LE Pelinka,H Redl,A Kröpfl,W Mauritz 📂 Article 📅 2002 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 1021 KB

Serum pseudouridine as a biochemical mar

Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma

✍ Yoshiki Amuro; Hiroko Nakaoka; Souji Shimomura; Mikio Fujikura; Tetsuo Yamamoto; 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 549 KB

“The beach position”: crossed legs as a

“The beach position”: crossed legs as a marker for a favourable clinical course in neurological intensive care unit patients

✍ Ulf C. Schneider; Peter Vajkoczy 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 142 KB

Serum S100β protein as a marker of disea

Serum S100β protein as a marker of disease activity in patients with malignant melanoma

✍ Muneeruddin Q. Mohammed; Hagosa D. Abraha; Roy A. Sherwood; Kenneth MacRae; Spyr 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 174 KB

Protein S-100B as a serum marker of brai

Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results

✍ A. Raabe, V. Seifert 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 40 KB

Procalcitonin as a prognostic marker for

Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit

✍ Maartje A. J. van den Broek; Steven W. M. Olde Damink; Bjorn Winkens; Christoph 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Clinically significant infections (CSIs) are life-threatening but difficult to diagnose after liver transplantation (LTx). This study investigates the value of procalcitonin (PCT) in addition to c-reactive protein (CRP) and the leukocyte count (LC) as a prognostic marker for CSIs in LTx recipients.